Skip to the content
Investors
Careers
Seek Labslogo darklogo light
  • About Us
  • Innovations
    • BioSeeker™ Discovery Engine
    • PTAP™ Therapeutics
    • SeekIt™ Diagnostics
  • Seekers
  • Partnering
  • News
  • Contact Us
Seek Labs
  • About Us
  • Innovations
    • BioSeeker™ Discovery Engine
    • PTAP™ Therapeutics
    • SeekIt™ Diagnostics
  • Seekers
  • Partnering
  • News
  • Contact Us
Seek Labs
  • About Us
  • Innovations
    • Therapeutics
    • Diagnostics
      • Point of Care Use Cases
      • Key Innovations
      • Communication
      • SeekIt™
  • Seekers
  • Partnering
  • News
  • Contact Us
  • Investors
  • Careers
Diagnostics Featured

Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform

Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform Built in a matter of months, Seek Labs’ functional investigationa

Bridget Baldwin
August 13, 2025
0 Comments
Featured Therapeutics

Seek Labs Maps High-Burden Mosquito-Borne Infectious Diseases with BioSeeker™

Seek Labs Maps High-Burden Mosquito-Borne Infectious Diseases with BioSeeker™, Accelerating Therapeutic Discovery for Chikungunya, West Nile Virus, and Zika August 5, 2025 Salt L

Bridget Baldwin
August 5, 2025
0 Comments
Featured Therapeutics

Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas

Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains July 22, 2025 SALT LA

Bridget Baldwin
July 22, 2025
0 Comments
Corporate Featured Therapeutics

BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)

BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV) July 8, 2025 Read the Medium Article from our CEO, Jared Bauer

Bridget Baldwin
July 8, 2025
0 Comments
Featured Therapeutics

Seek Labs Maps Measles Virus with BioSeeker™, Opening the Door to First-Ever Programmable Antiviral Therapeutic Amid Global Outbreaks

Seek Labs Maps Measles Virus with BioSeeker™, Opening the Door to First-Ever Programmable Antiviral Therapeutic Amid Global Outbreaks June 23, 2025 Read the Medium Article from o

Bridget Baldwin
June 23, 2025
0 Comments
Featured Therapeutics

Seek Labs Unveils BioSeeker™

Seek Labs Unveils BioSeeker™ Bioseeker™ is the AI Discovery Engine Powering Seek Labs’ Mission to Outpace Disease with Faster, Smarter Global Health Solutions June 10, 2025 R

Bridget Baldwin
June 10, 2025
0 Comments
Corporate Featured

Seek Labs Announces Leadership Transition as Keith Marmer, President, Joins Board of Directors

Seek Labs Announces Leadership Transition as Keith Marmer, President, will Join Board of Directors May 23, 2025 Seek Labs today announced Keith Marmer’s transition from President

Bridget Baldwin
May 23, 2025
0 Comments
Diagnostics Featured

Seek Labs Takes the Stage at Aquaculture 2025

Seek Labs Showcases SeekIt™ at Aquaculture 2025 March 24, 2024 Seek Labs was proud to participate in Aquaculture 2025 in New Orleans, LA. Our VP of Research, Dr. Annie Roy, prese

Bridget Baldwin
March 24, 2025
0 Comments
Corporate Featured

Seek Labs Appoints Kim Wirthlin as Chief Strategy Officer

Seek Labs Appoints Kim Wirthlin as Chief Strategy Officer March 19, 2025 SALT LAKE CITY, UT, March 19, 2024 (BusinessWire)- Seek Labs, a healthcare innovations company developing d

Bridget Baldwin
March 19, 2025
0 Comments
Diagnostics Featured

Seek Labs Featured in the Global Seafood Advocate

Seek Labs Recognized in the Global Seafood Advocate for Advancing Aquaculture Disease Detection March 11, 2025 Seek Labs is proud to be featured in the Global Seafood Advocate for

Bridget Baldwin
March 11, 2025
0 Comments

Posts pagination

1 2 3 4 5
350 W 800 N, Suite 220
Salt Lake City, UT 84103
  • About Us
  • Seekers
  • Contact Us
  • Investors
  • Quality Policy
  • Innovations
  • Therapeutics
  • Diagnostics

    By submitting this form, you agree to our Terms of Service and Privacy Policy.

    Multiple Patents Pending | Copyright 2023 All Rights Reserved

    Terms of Service | Privacy Policy

    BioSeeker, PTAP, and SeekIt are investigational platforms currently in preclinical development. Not cleared or approved by the FDA or any other regulatory agency..

    Back to top Drag